良性子宫疾病子宫切除术90天整体计费周期内的住院费用与手术途径比较
基于Premier医疗数据库2000至2020年400,977例子宫切除术患者,比较不同手术途径的住院费用与并发症。阴式子宫切除术住院总费用最低(6,524.00美元),机器人辅助腹腔镜最高(9,386.80美元)。机器人辅助途径费用较高,微创手术并发症率低,机器人辅助似乎未显著改善围手术期结局。
要点
- 阴式子宫切除术住院总费用最低,机器人辅助腹腔镜最高,固定与可变费用差异持续存在。
- 与阴式相比,开腹子宫切除术并发症率更高(aOR 1.52,95%CI 1.39-1.67)。
- 与阴式相比,腹腔镜(aOR 0.85,95%CI 0.80-0.89)和机器人辅助(aOR 0.92,95%CI 0.84-1.00)并发症率更低。
核心结论
- 机器人辅助子宫切除术与其他途径相比手术费用更高,即使考虑外科医生手术量后仍如此。
- 微创手术并发症率低,机器人辅助途径似乎未显著改善围手术期结局。
研究设计与样本
- 使用Premier医疗数据库识别2000至2020年间接受子宫切除术的患者,共400,977例。
- 根据当前操作术语代码按手术途径分组,使用国际疾病分类代码识别合并症和并发症。
- 比较住院固定费用、可变费用和总费用,采用方差分析、t检验和χ²检验分析。
- 采用线性混合效应模型评估与总费用增加独立相关的因素,多因素logistic回归评估手术途径与并发症率的关联。
主要发现
- 阴式子宫切除术住院总费用最低(6,524.00美元[四分位距4,831.60,8,785.70]),机器人辅助腹腔镜子宫切除术总费用最高(9,386.80美元[四分位距6,912.40,12,506.90])。
- 固定费用和可变费用的差异与总费用差异持续存在。
- 与阴式子宫切除术相比,开腹子宫切除术并发症率更高(aOR 1.52,95%CI 1.39-1.67)。
- 与阴式子宫切除术相比,腹腔镜子宫切除术并发症率更低(aOR 0.85,95%CI 0.80-0.89),机器人辅助子宫切除术并发症率更低(aOR 0.92,95%CI 0.84-1.00)。
- 高手术量腹腔镜和机器人辅助外科医生(每年超过50例)与阴式子宫切除术的费用差异减小。
关键数值与推荐
- 阴式子宫切除术住院总费用6,524.00美元(四分位距4,831.60,8,785.70)。
- 机器人辅助腹腔镜子宫切除术住院总费用9,386.80美元(四分位距6,912.40,12,506.90)。
- 开腹子宫切除术与阴式相比并发症aOR 1.52(95%CI 1.39-1.67)。
- 腹腔镜子宫切除术与阴式相比并发症aOR 0.85(95%CI 0.80-0.89)。
- 机器人辅助子宫切除术与阴式相比并发症aOR 0.92(95%CI 0.84-1.00)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare inpatient hospital costs and complication rates within the 90-day global billing period among routes of hysterectomy. METHODS: The Premier Healthcare Database was used to identify patients who underwent hysterectomy between 2000 and 2020. Current Procedural Terminology codes were used to group patients based on route of hysterectomy. Comorbidities and complications were identified using International Classification of Diseases codes. Fixed, variable, and total costs for inpatient care were compared. Fixed costs consist of costs that are set for the case, such as operating room time or surgeon costs. Variable costs include disposable and reusable items that are billed additionally. Total costs equal fixed and variable costs combined. Data were analyzed using analysis of variance, t test, and χ 2 test, as appropriate. Factors independently associated with increased total costs were assessed using linear mixed effects models. Multivariate logistic regression was performed to evaluate associations between the route of surgery and complication rates. RESULTS: A cohort of 400,977 patients were identified and grouped by route of hysterectomy. Vaginal hysterectomy demonstrated the lowest inpatient total cost ($6,524.00 [interquartile range $4,831.60, $8,785.70]), and robotic-assisted laparoscopic hysterectomy had the highest total cost ($9,386.80 [interquartile range $6,912.40, $12,506.90]). These differences persisted with fixed and variable costs. High-volume laparoscopic and robotic surgeons (more than 50 cases per year) had a decrease in the cost difference when compared with costs of vaginal hysterectomy. Abdominal hysterectomy had a higher rate of complications relative to vaginal hysterectomy (adjusted odds ratio [aOR] 1.52, 95% CI, 1.39-1.67), whereas laparoscopic (aOR 0.85, 95% CI, 0.80-0.89) and robotic-assisted (aOR 0.92, 95% CI, 0.84-1.00) hysterectomy had lower rates of complications compared with vaginal hysterectomy. CONCLUSION: Robotic-assisted hysterectomy is associated with higher surgical costs compared with other approaches, even when accounting for surgeon volume. Complication rates are low for minimally invasive surgery, and it is unlikely that the robotic-assisted approach provides an appreciable improvement in perioperative outcomes.
引用
- Bauer HH, Sahmoud A, Rhodes SP, et al. Inpatient Hospital Costs and Route of Hysterectomy for Management of Benign Uterine Disease in the 90-Day Global Billing Period. Obstet Gynecol. 2024. PMID: 38870524. doi:10.1097/AOG.0000000000005643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。